Atıf İçin Kopyala
Anckaert E., Oktem M., Thies A., Cohen-Bacrie M., Daan N. M. P., Schiettecatte J., ...Daha Fazla
CLINICAL BIOCHEMISTRY, cilt.49, sa.3, ss.260-267, 2016 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
49
Sayı:
3
-
Basım Tarihi:
2016
-
Doi Numarası:
10.1016/j.clinbiochem.2015.10.008
-
Dergi Adı:
CLINICAL BIOCHEMISTRY
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.260-267
-
Anahtar Kelimeler:
Immunoassay, Anti-Mullerian hormone (AMH), Electrochemiluminescence immunoassay (ECLIA), Polycystic ovary syndrome (PCOS), Elecsys (R) AMH, POLYCYSTIC-OVARY-SYNDROME, MLLERIAN HORMONE, SYNDROME PCOS, MOUSE OVARY, IN-VITRO, GEN II, DEFINITION, WOMEN, REPRODUCIBILITY, IMMUNOASSAY
-
Gazi Üniversitesi Adresli:
Hayır
Özet
Objectives: Anti-Mullerian hormone (AMH) is an established biomarker for assessing ovarian reserve and predicting response to controlled ovarian stimulation. Its routine clinical use is hampered by the variability and low-throughput of available enzyme-linked immunosorbent assays (ELISA). The presented study examined if a fully automated AMH electrochemiluminescence assay (ECLIA; Elecsys (R) AMH assay, Roche Diagnostics) was suitable for measuring AMH levels in healthy women and in those diagnosed with polycystic ovary syndrome (PCOS).